Callan JMB Inc. (NASDAQ:CJMB – Get Free Report) saw a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 167,369 shares, a growth of 539.2% from the July 15th total of 26,183 shares. Based on an average daily volume of 10,218,062 shares, the short-interest ratio is presently 0.0 days. Currently, 11.3% of the company’s stock are sold short.
Hedge Funds Weigh In On Callan JMB
An institutional investor recently bought a new position in Callan JMB stock. Bard Associates Inc. bought a new position in Callan JMB Inc. (NASDAQ:CJMB – Free Report) in the second quarter, according to its most recent filing with the SEC. The firm bought 229,250 shares of the company’s stock, valued at approximately $184,000. Bard Associates Inc. owned approximately 4.05% of Callan JMB as of its most recent SEC filing.
Callan JMB Trading Up 1.0%
Shares of CJMB traded up $0.02 during midday trading on Thursday, hitting $2.21. 139,488 shares of the company’s stock traded hands, compared to its average volume of 2,403,249. Callan JMB has a 1 year low of $0.65 and a 1 year high of $5.61. The firm’s fifty day moving average is $1.14 and its 200-day moving average is $1.31. The stock has a market capitalization of $12.52 million, a price-to-earnings ratio of -1.07 and a beta of -0.73.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Callan JMB in a report on Friday, July 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.
Read Our Latest Research Report on CJMB
About Callan JMB
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.
See Also
- Five stocks we like better than Callan JMB
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.
